Genmab A/S revised earnings guidance for the year 2022. For the year, the company now expects revenue to be DKK 12,000 million - DKK 13,000 million and operating profit to be DKK 3,800 million - DKK 5,400 million against previous guidance of revenue of DKK 11,000 million - DKK 12,000 million and operating profit to be DKK 3,200 million - DKK 4,800 million.